Newsroom
Stay current with industry announcements, regulatory updates, and market developments.
Regulators in the US, Europe, and Asia are synchronizing review timelines, reshaping how pipelines are prioritized.
Venture funding is returning to biotech with a sharper focus on solid clinical data and clear commercial paths.
Contract development and manufacturing organizations are retooling capacity to support advanced biologics and cell therapies.
Connect. Collaborate. Scale your opportunities with the right network.
